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0929-6646/Copyright ª 2015, ElsevierBackground/Purpose: Patients with diabetes are at a high risk of infection-related morbidity
and mortality. Klebsiella pneumoniae bacilli are prevalent among diabetic patients, especially
in Asian populations. The present study aimed to identify risk factors for in-hospital mortality
among diabetic patients complicated by community-acquired K. pneumoniae bacteremia.
Methods: We evaluated the clinical characteristics of 341 Taiwanese type 2 diabetic patients
who were treated for community-acquired K. pneumoniae bacteremia. We then analyzed
outcome predictors, and in particular comorbidities and the site of infection.
Results: The overall in-hospital mortality rate was 14.1%. Comorbid cancer was the leading
factor, accounting for 32.1% of all cases of mortality. Pulmonary infection, primary bacter-
emia, afebrile or shock presentation and low serum albumin level were risk factors for in-
hospital mortality. Regardless of comorbidities, pulmonary infection [odds ratio (OR) 10.74,
95% confidence interval (CI) 2.02e57.09] and albumin level (OR 0.15, 95% CI 0.03e0.76) were
the main risk predictors. The receiver operating characteristic curve indicated that a serum
albumin level lower than 2.4 g/dL (71.1% sensitivity and 77.4% specificity) suggested a poor
prognosis in the diabetic patients with K. pneumoniae bacteremia. In patients with pulmonary
infection, the capsular serotypes of K. pneumoniae were not related to poor outcomes, and an
initial presentation of blunted fever or shock were independent factors for mortality.have no conflicts of interest relevant to this article.
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Mortality in Klebsiella pneumoniae bacteremia 917Conclusion: Cancer, pulmonary infection, and low serum albumin levels were independent in-
dicators of in-hospital mortality in the diabetic patients complicated by K. pneumoniae bacter-
emia. The sites of infection and host characteristics should always elicit medical attention
when treating these patients.
Copyright ª 2015, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Infectious diseases are known to cause complications in
patients with diabetes,1 and diabetic patients have been
reported to have a 4.4-fold higher risk of bacteremia
compared to patients without diabetes.2 In addition to a
higher risk of morbidities,1,3 patients with diabetes have
also been reported to be at a higher risk of death from
infectious diseases.4 The hazard ratio for death due to in-
fections is as high as that for vascular diseases in patients
with diabetes (2.39 vs. 2.32, respectively).4 Nevertheless,
few reports have investigated the outcome predictors for
mortality in patients with diabetes complicated by severe
infections.
K. pneumoniae, a Gram-negative bacillus, causes
infection with a high mortality rate.5,6 Many reports have
suggested that patients with diabetes are at a high risk of K.
pneumoniae infections,2,7e10 possibly because of impair-
ment of bacterial phagocytosis in patients with diabetes.11
The incidence of K. pneumoniae infection has been re-
ported to be higher in Taiwan, other Asian countries, and
South Africa, especially as a unique presentation of liver
abscess.7
In this study, we aimed to investigate the clinical fea-
tures affecting in-hospital mortality in patients with type 2
diabetes complicated by community-acquired K. pneumo-
niae bacteremia.Patients and methods
In this retrospective study, we reviewed and analyzed 341
consecutive patients with type 2 diabetes who were
admitted to Chang Gung Memorial Hospital, Taoyuan,
Taiwan (a 3,700-bed medical center) between January 2005
and December 2008 and who were diagnosed with
community-acquired K. pneumoniae bacteremia. The
Institutional Review Board of Chang Gung Memorial Hospital
approved this study (No. 100-0417B).
K. pneumoniae bacteremia was defined as the isolation
of K. pneumoniae in one or more blood cultures in associ-
ation with the clinical features of bacteremia and/or
sepsis. Community-acquired bacteremia was defined as a
positive blood culture taken on admission or within 48 hours
of admission. The blood cultures of all 341 patients were
collected within 48 hours of admission and documented as
K. pneumoniae.
The diagnosis of diabetes mellitus and major comorbid-
ities were made by thoroughly reviewing medical records.
The patients with a tympanic temperature lower than 38C
at admission were considered to have a blunted feverresponse. Meanwhile, the patients with an initial systolic
blood pressure lower than 90 mmHg or requiring an
inotropic agent within the first 2 days of admission were
defined as having septic shock.
We thoroughly investigated the primary site of the K.
pneumoniae infection during the hospital stay. Imaging
studies, based on a K. pneumoniae-positive local tissue or
fluid culture, clinically confirmed the site of infection. We
defined patients without a detectable primary site of
infection as having K. pneumoniae primary bacteremia, and
multifocal infection as the presence of more than one pri-
mary site of infection.
In the bacteremic pneumonia group, available bacterial
isolates from 24 patients were further examined microbi-
ologically. To analyze the impact of capsule serotypes on
the clinical outcomes in this specific high-mortality group of
patients, we performed polymerase chain reaction for
capsular K serotyping.12
We analyzed the correlation between serum albumin
level and mortality using a receiver operating characteristic
(ROC) curve, and we calculated the best cutoff point based
on the Youden index. We used SPSS software version 16.0
(IBM SPSS Inc., Chicago, IL, USA) for all statistical analyses.
We used independent sample t test and Chi-square test as
appropriate to compare variables in the patients who died
and those who survived. Multivariate analysis with binary
logistic regression was applied to identify the independent
factors for in-hospital mortality. We used one-way analysis
of variance and Chi-square test as appropriate to compare
variables in the patients with the three major sites of
infection. All statistical tests were performed at a two-
tailed significance level of 0.05.Results
Patients’ demographic characteristics, diabetes
status, and in-hospital mortality
The mean age of the 341 patients was 63.0  13.2 years,
and the male-to-female ratio was 55.1%. The mean dura-
tion of diabetes was 7.9  7.2 years, with a mean serum
glycated hemoglobin level of 9.3  2.7% at admission.
Among the 341 patients, 6.5% had coronary artery disease,
16.7% had a history of stroke, and 6.2% had end-stage renal
disease and were on maintenance hemodialysis (Table 1).
K. pneumoniae bacteremia primarily caused the death
of 48 of the 341 patients during the study period. The
overall in-hospital mortality rate was 14.1% (Tables 1 and
2). The three leading comorbidities in this studies partici-
pants were cancer (15.5%), cirrhosis (11.1%), and chronic
Table 1 Factors associated with in-hospital mortality in diabetic patients with community-acquired Klebsiella pneumoniae
bacteremia.
All cases
(n Z 341)
Mortality
(n Z 48)
Survival
(n Z 293)
p
Demographic data and diabetic
vascular complications
Age (y) 63.0  13.2 64.7  12.7 62.8  13.4 0.338
Male 188 (55.1) 29 (60.4) 159 (54.1) 0.413
Duration of diabetes (y) 7.9  7.2 8.2  7.0 7.9  7.5 0.879
Glycated hemoglobin levels (%) 9.3  2.7 8.6  2.8 9.4  2.7 0.254
History of stroke 57 (16.7) 11 (22.9) 46 (15.6) 0.267
History of CAD 22 (6.5) 4 (8.3) 18 (6.1) 0.563
Hemodialysis 21 (6.2) 4 (8.3) 17 (5.8) 0.507
Major comorbidities Cancer 53 (15.5) 17 (35.4) 36 (12.2) < 0.001
Liver cirrhosis 38 (11.1) 8 (16.7) 30 (10.2) 0.042
Chronic steroid use 8 (2.3) 3 (6.2) 5 (1.7) 0.073
Site of primary infection Pneumonia 42 (12.3) 16 (33.3) 26 (8.9) < 0.005
Primary bacteremia 48 (14.1) 12 (25) 36 (12.3) 0.019
Soft-tissue infection 20 (5.9) 5 (10.4) 15 (5.1) 0.148
Liver abscess 81 (23.8) 2 (2.5) 79 (97.5) 0.001
Clinical manifestations and
laboratory findings
Afebrile state 97 (28.4) 26 (54.2) 71 (24.5) < 0.005
Initial presentation of shock 64 (18.8) 31 (64.6) 33 (11.2) < 0.005
Polymicrobial bacteremia 61 (17.9) 13 (27.1) 48 (16.3) 0.071
C-reactive protein levels (mg/L) 190.3  126.3 213.2  127.2 186.9  126.1 0.282
White blood cell count ( 103/mL) 12.9  7.5 13.2  9.6 12.9  7.2 0.817
Albumin (g/dL) 2.6  0.6 2.2  0.6 2.7  0.5 < 0.005
eGFR (mL/min/1.73 m2) 55.1  32.9 44.5  31.4 56.7  32.8 0.018
Data presented as n (%) or mean  standard deviation for continuous variables.
CAD Z coronary artery disease; eGFR Z estimated glomerular filtration rate.
918 C.-H. Huang et al.steroid usage for various diseases (2.3%; Table 1). Twenty-
eight of 99 patients with major comorbidities died (mor-
tality rate, 28.3%). Twenty of the 242 patients who did not
have comorbidities died (mortality rate, 8.3%). The mor-
tality rates between these two groups were significantly
different (p < 0.001).Risk factors for in-hospital mortality among the
diabetic patients with K. pneumoniae bacteremia
Based on multivariate analysis using binary logistic regres-
sion analysis, comorbid cancer appeared to be anTable 2 Independent factors associated with in-hospital mort
moniae bacteremia.
Variables All patients (n Z 341; mortality 14
Adjusted OR 95% CI
Cancer 3.545 1.060e11.853
Pneumonia 6.158 1.669e22.724
Afebrile state 3.352 1.195e9.398
Initial shock 5.739 2.088e15.770
Albumin level 0.182 0.064e0.518
Primary bacteremia 3.918 1.043e14.715
Factors for this multivariate logistic regression were determined by
included factors were cancer, cirrhosis, chronic steroid use, pneumon
albumin level, and estimated glomerular filtration rate. For patients w
liver abscess, afebrile state, initial shock, and albumin level. The sur
CI Z confidence interval; OR Z odds ratio.independent factor for a poor outcome. The cause-specific
in-hospital mortality rate in diabetic patients with cancer
comorbidity was 32.1% [17/53; odds ratio (OR) 3.55, 95%
confidence interval (CI) 1.06e11.85].
The other indicators for mortality were pulmonary
infection (OR 6.16, 95% CI 1.67e22.72), primary bacteremia
(OR 3.92, 95% CI 1.04e14.72), being clinically afebrile (OR
3.35, 95% CI 1.20e9.40), shock (OR 5.74, 95% CI
2.09e15.77), and serum albumin level (OR 0.18, 95% CI
0.06e0.52). For the patients with diabetes who had no
comorbidities, the indicators were pulmonary infection (OR
10.74, 95% CI 2.02e57.09) and serum albumin level (OR
0.15, 95% CI 0.03-0.76; Table 2).ality in diabetic patients with community-acquired K. pneu-
.1%) Patients without major comorbidities
(n Z 242; mortality 8.3%)
p Adjusted OR 95% CI p
0.040 d d d
0.006 10.743 2.022e57.085 0.005
0.021 4.563 0.924e22.538 0.062
0.001 3.670 0.778e17.305 0.100
0.001 0.154 0.031e0.755 0.021
0.043 d d d
significant factors in univariate analysis. For all patients, the
ia, primary bacteremia, liver abscess, afebrile state, initial shock,
ithout major comorbidities, the included factors were pneumonia,
vival group was used as the baseline in both regression models.
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level did not seem to have direct impacts on in-hospital
mortality. Complications related to diabetes such as stroke
and coronary artery disease, and those under maintenance
hemodialysis were not associated with poor outcomes.
The prognosis of the patients with hypoalbuminemia,
with or without major comorbidities, was poor (Table 2).
Analysis of the ROC curve revealed that a serum albumin
level of 2.4 g/dL was a cutoff value with 71.1% sensitivity
and 77.4% specificity. The risk of mortality for the patients
with a serum albumin level below 2.4 g/dL was 9.38 times
higher (adjusted OR 9.38, 95% CI 3.15e27.94) than for the
patients with a serum albumin level higher than 2.4 g/dL.
For the 242 patients with no comorbidities, the cutoff value
of serum albumin level was also 2.4 g/dL (adjusted OR 7.95,
95% CI 1.62e39.08).Sites of infection and mortality rates
As shown in Figure 1, the bacteremic liver abscess was the
most common focal infection (23.7%), followed by urinary
tract infection (18.5%) and primary bacteremia (14.1%).
The group with bacteremic pneumonia had the highestFigure 1 Sites of infection and site-specific mortality in the
patients with diabetes complicated by Klebsiella pneumoniae
bacteremia. The subgroups were sorted by prevalence and are
presented in descending order. The stacked vertical bars
represent survival (white) and in-hospital mortality (black) of
the patients with diabetes complicated by K. pneumoniae
bacteremia, grouped according to the site of infection. The
label above each white bar indicates the prevalence in that
subgroup. The label above each black bar indicates the in-
hospital mortality rate in that subgroup. “Other focal in-
fections” includes seven patients with spontaneous peritonitis,
six patients with prostatic abscess, five cases with anal ab-
scess, four cases with acute pancreatitis, three patients with
acute appendicitis, three patients with endophthalmitis, and
one case with splenic abscess.mortality rate (38%), followed by the groups with primary
bacteremia (25%), soft tissue infection (25%), and central
nervous system infection (25%). The group with a bacter-
emic liver abscess had a mortality rate of only 2.5%.
Approximately 5% of the patients had multifocal organ in-
fections, with a mortality rate of 17.6%.
Comparison of the indicators between major sites
of infection
Table 3 demonstrates comparisons of clinical characteris-
tics between the three different major sites of infection:
bacteremic liver abscess (the most common site of infec-
tion with the lowest mortality rate), bacteremic pneu-
monia, and primary bacteremia. The patients with a K.
pneumoniae liver abscess were more likely to be young,
have a normal body mass index (BMI), and present with
fewer comorbidities. By contrast, the patients with
bacteremic pneumonia and primary bacteremia were more
likely to be older, have a lower BMI, higher rate of comor-
bidities and shock, or to be afebrile.
Analysis of the risk factors for mortality in the
bacteremic pneumonia group
Since bacteremic pneumonia was the site of infection most
related to a high mortality rate, we studied capsular sero-
typing in this specific group. The capsular serotyping of the
available 24 isolates of K. pneumoniae identified the
following serotypes: four K1, four K2, and 16 non-K1/K2
serotypes. Thus, the K1 and K2 serotypes accounted for
only one third of the isolates. Six of the 24 patients died,
and the capsular serotyping of these six patients showed
that one had the K1 serotype and five had the non-K1/K2
serotype. The serotype distribution was diverse and was
not associated with in-hospital mortality. We therefore
analyzed the clinical factors in this bacteremic pneumonia
group (Table 4), and found that initial shock (adjusted OR
16.99, 95% CI 2.69e107.14) and a blunted fever response
(adjusted OR 15.99, 95% CI 1.91e133.55) were predictors of
in-hospital mortality.
Discussion
Community-acquired infection is a serious complication for
diabetic patients. This study examined the in-hospital risk
factors for mortality in a large group of diabetic patients
with community-acquired K. pneumoniae bacteremia. We
identified comorbid cancer, pulmonary infection, primary
bacteremia, being afebrile or in shock, and lower serum
albumin level as indicators of mortality. Patients with type
2 diabetes mellitus more commonly have comorbid sys-
temic disorders and cancer compared to patients without
diabetes,13,14 and we found that the in-hospital mortality
rate was different between those with (28.3%) and without
(8.3%) comorbid diseases. For the patients with comorbid
cancer, the mortality rate increased to 35.4%. Notably, in-
dicators other than comorbid diseases such as pulmonary
infection and low serum albumin level were noted in the
patients either with or without comorbidities.
Table 3 Comparison of parameters between the three major sites of infection.
Bacteremic liver abscesses Bacteremic pneumonia Primary bacteremia p
n 81 42 48
Mortality rate 2 (2.5) 16 (38.1) 12 (25) < 0.005
Age (y) 58.9  12.2 65.9  14.6 69.4  11.2 < 0.005
Male 51 (63.0) 31 (73.8) 24 (50) 0.066
Body mass index (kg/m2) 24.5  2.7 21.9  4.5 23.3  2.9 0.003
Duration of diabetes (y) 6.0  6.1 9.3  7.4 9.0  7.2 0.047
Glycated hemoglobin (%) 10.3  2.9 8.9  2.8 9.4  2.8 0.107
Hemodialysis 2 (2.5) 4 (9.5) 3 (6.2) 0.233
History of stroke 9 (11.1) 15 (35.7) 8 (16.7) 0.012
History of CAD 3 (3.7) 6 (14.3) 1 (2.1) 0.025
Cancer 3 (3.7) 15 (35.7) 12 (25.0) <0.005
Cirrhosis 6 (7.4) 5 (11.9) 11 (22.9) 0.039
Chronic steroid usage 0 2 (4.8) 4 (8.3) 0.040
C-reactive protein (mg/L) 211.6  115.4 210.6  111.0 152.1  112.7 0.056
White blood cell count ( 103/mL) 12.2  6.7 12.5  9.1 11.8  8.1 0.920
eGFR (mL/min/1.73 m2) 58.7  28.7 54.8  32.3 44.5  23.7 0.032
Albumin (g/dL) 2.7  0.5 2.5  0.5 2.6  0.7 0.157
Afebrile state 6 (7.4) 7 (16.7) 11 (22.9) 0.010
Initial presentation of shock 12 (14.8) 16 (38.1) 9 (18.8) 0.001
Polymicrobial bacteremia 7 (8.6) 9 (21.4) 17 (35.4) 0.001
Data presented as n (%) or mean  standard deviation for continuous variables.
CAD Z coronary artery disease; eGFR Z estimated glomerular filtration rate.
920 C.-H. Huang et al.As previously reported,15 a blunted fever response to a
serious bacterial, viral, or fungal infection suggests a
poorer prognosis than a robust fever response.16 The lack of
a robust febrile response may be associated with a greater
risk of mortality in patients with hospital-acquired bacter-
emia, and a blunted fever response may reflect a failure of
the host to respond to the infection.
A low albumin level was a predictor of the outcome of K.
pneumoniae bacteremia in the diabetic patient with or
without comorbidities. A previous study reported similar
observations of a low albumin level and higher mortality
rate in other bloodstream infections.17 Although serum al-
bumin levels usually reflect the nutritional status of a pa-
tient, the low serum albumin levels in patients with sepsis
may be due to catabolism exacerbated by septicemia.18 Our
results further revealed that a serum albumin level lower
than 2.4 g/dL led to a 9.38-fold higher risk of in-hospital
mortality in the patients with community-acquired K.
pneumoniae bacteremia. Whether albumin supplementa-
tion should be recommended to patients with acute ill-
nesses remains controversial.19
The in-hospital mortality rates varied according to the
site of infection, from 2.5% in patients with liver abscesses
to 38.1% in those with pulmonary infections. Medical
attention on the site of infection should be provided while
treating for K. pneumoniae bacteremia. A multi-center
study in Taiwan reported that Klebsiella spp. were com-
mon pathogens in patients with community-acquired
pneumonia.20 Similarly, Meatherall et al6 reported that
diabetic patients with pneumonia had a high mortality rate
of 42%, compared to 25% in patients with primary bacter-
emia and 7% in patients with liver abscesses in both
community-acquired and nosocomial K. pneumoniae
bacteremia. Wu et al21 reported a similar trend of mortalityfor pneumonia, primary bacteremia, and liver abscesses in
Taiwanese patients with K. pneumoniae bacteremia. When
the liver is the site of K. pneumoniae infection, the bac-
teria seem to be restricted in the solid organ, thus forming
abscesses. Therapeutic drainage and removal of the bac-
teria from the abscesses may have been another contrib-
uting factor to the good outcomes in our study. When the
lung is the site of infection, the pulmonary tissue seems to
be more vulnerable to the bacteria. In addition, we found
that the characteristics of the host also explained this
finding. Based on our analysis, the patients with liver ab-
scesses were younger, had a lower incidence of associated
comorbidities, and were relatively healthy as indicated by
their BMIs compared with the patients with lung infections
or primary bacteremia.
The K1 and K2 bacterial capsular serotypes have been
demonstrated to cause virulent and invasive syndromes in
patients with liver abscesses.12,22,23 However, the mortality
rate of the liver abscess group was not significantly worse in
this study. Yu at al24 reported a strong association between
the K1/K2 serotypes and pneumonia. Of note, the K1/K2
serotypes were not correlated with in-hospital mortality in
our pneumonia group, and the independent risk factors in
this specific group were the clinical manifestations of a
blunted fever or septic shock, suggesting that a fulminant
infection at admission determined the outcome of the pa-
tients with diabetes who had K. pneumoniae bacteremic
pneumonia. Lin et al25 also reported that the K1/K2 sero-
types did not predispose patients to a poor clinical outcome
from community-acquired K. pneumoniae among the gen-
eral population.
High blood sugar levels have been shown to impair the
phagocytic defense against K. pneumoniae in patients with
diabetes.11 Moreover, acute metabolic decompensation
Table 4 Factors associated with in-hospital mortality in
the patients with bacteremic pneumonia.
Bacteremic pneumonia (n Z 42)
Mortality
(n Z 16)
Survival
(n Z 26)
p
Age (y) 61.5  12.9 68.5  15.2 0.118
Male 12 (75) 19 (73.1) > 0.99
Body mass index
(kg/m2)
20.5  4.7 22.5  4.3 0.291
Duration of
diabetes (y)
7.1  5.6 10.9  8.3 0.157
Glycated
hemoglobin (%)
11.5  3.0 8.4  2.6 0.121
Hemodialysis 1 (6.3) 3 (11.5) > 0.99
History of stroke 5 (31.3) 10 (38.5) 0.740
History of CAD 2 (12.5) 4 (15.4) > 0.99
Cancer 6 (37.5) 9 (34.6) > 0.99
Cirrhosis 3 (18.8) 2 (7.7) 0.632
Chronic steroid
usage
0 2 (7.7) 0.517
C-reactive protein
(mg/L)
229.7  126.8 199.6  104.3 0.579
White blood cell
count ( 103/mL)
11.5  1.0 13.1  8.5 0.610
eGFR
(mL/min/1.73 m2)
47.4  24.8 59.1  35.7 0.226
Albumin (g/dL) 2.4  0.6 2.6  0.4 0.296
Afebrile state 9 (56.3) 2 (7.7) 0.004a
Initial presentation
of shock
12 (75) 4 (15.4) <0.005a
Polymicrobial
bacteremia
4 (25) 5 (19.2) 0.711
Data presented as n (%) or mean  standard deviation for
continuous variables.
CAD Z coronary artery disease; eGFR Z estimated glomerular
filtration rate.
a Independent risk factors after multivariate analysis by lo-
gistic regression.
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outcome in patients with diabetes.4 Nevertheless, glycated
hemoglobin levels did not affect mortality in this study. The
high mean glycated hemoglobin level, indicating chroni-
cally poor glycemic control among our patients, may have
increased the susceptibility to severe infection. A lower BMI
and lower serum albumin level may further indicate acute
illness. Therefore, our data should be interpreted with
caution, taking into account the fact that the glycated
hemoglobin level did not affect the mortality rate during
treatment for K. pneumoniae bacteremia. Yu et al26
reported that the significant impact of human glycemic
change in neutrophil phagocytosis of K. pneumoniae does
not reflect the seroepidemiology of K. pneumoniae be-
tween diabetic patients with strict or poor glycemic
control. These mechanisms may make it complex and
difficult to interpret the outcomes. It has been reported
that patients with diabetes do not have poorer outcomes
compared to patients without diabetes with regards to
bacteremia overall,2,27 bacteremia caused byenterobacteria,28,29 and K. pneumoniae liver abscess.30 In
contrast to comorbid cancer, the duration of diabetes and
severe preexisting chronic complications of diabetes such
as stroke, myocardial infarction, and maintenance hemo-
dialysis had little impact on the in-hospital mortality rate of
patients with K. pneumoniae bacteremia.
The main limitation of this study is its retrospective
nature. In addition, given that most of our patients were
not admitted to an intensive care unit, we did not apply
common mortality risk scores such as the Acute Physiology
and Chronic Health Evaluation.
We identified comorbid cancer, pulmonary infection,
and low serum albumin level as prognostic indicators of in-
hospital mortality in patients with diabetes who had
community-acquired K. pneumoniae bacteremia. These
factors also implied poor host characteristics. Clinicians
should be aware of these predictors when treating patients
with diabetes complicated by K. pneumoniae bacteremia.Acknowledgments
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